IPOs - Page 45 | TalkMarkets

Content

All Posts > Content under IPOs
705 to 720 of 1834 Posts
<<< 1 ... 43 44 45 46 47 ... 115 >>>
Week In Review: Alphamab Oncology Plans $350 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, December 7, 2019 5:15 PM EDT
Alphamab Oncology, a company developing eight bispecifics for oncology, plans to stage an IPO before the end of the year on the Hong Kong Exchange that could raise up to $350 million.
In this article: AZN, JNJ, MRK, CASI, ASLN
Read
Aramco Prices IPO At Top-End Of Range: Raises Record $25.6BN In World's Biggest IPO
Article By: Tyler Durden
Thursday, December 5, 2019 2:48 PM EDT
Saudi Aramco just priced its IPO at the high end of the targeted range, selling 3 billion shares or a 1.5% stake at 32 riyals ($8.53) per share for a total of $25.6 billion, and giving the oil giant a market valuation of $1.7 trillion.
In this article: PTR, AAPL, BABA
Read
Are IPOs A Warning Sign?
Article By: MoneyShow.com
Sunday, December 1, 2019 1:13 AM EDT
Long duration bull markets always create excesses. And to many participants in the investing world, these potentially dangerous extremes are often invisible.
Read
Week In Review: Pharmaron, A Beijing CRO, Stages $434 Million Hong Kong IPO
Article By: ChinaBio® Today
Saturday, November 30, 2019 4:07 PM EDT
Pharmaron Beijing staged a $434 million Hong Kong IPO to expand its international CRO operations. In January, Pharmaron completed a $76 million IPO on the Shenzhen Exchange, and its stock price has quadrupled since its debut.
In this article: MRK
Read
Alibaba Shares Surge In Hong Kong IPO Debut
Article By: Benzinga
Tuesday, November 26, 2019 4:12 AM EDT
Alibaba Group Holding Limited made an impressive homecoming debut at the Hong Kong Stock Exchange on Tuesday (Beijing time).
In this article: BABA
Read
Week In Review: Fosun Pharma Acquires Brain Cancer Immunotherapy In $148 Million Deal
Article By: ChinaBio® Today
Saturday, November 23, 2019 4:26 PM EDT
Shanghai Fosun Pharma announced a $148 million agreement to acquire China rights for SurVaxM, a novel immunotherapy aimed at glioblastoma, from MimiVax of Buffalo, New York.
In this article: NVS
Read
Markets Not “All In” On Saudi Aramco IPO, China-US Trade Deal Strokes Fears
Article By: Joe Perry
Tuesday, November 19, 2019 12:00 PM EDT
Multiple international investors have reportedly told Saudi Aramco that they would limit participation in the IPO if it is valued of USD 1.5 Trillion. In addition, comments out of China are also affecting the oil market.
In this article: OIL, UCO
Read
How Will Saudi Aramco IPO Affect The Oil Market?
Article By: Maithya Kitonyi
Tuesday, November 19, 2019 11:02 AM EDT
Saudi Aramco's IPO, which values the company at a discounted $1.7 trillion is still deemed expensive by some analysts. So how will this affect the general oil and gas market?
In this article: XOM, AAPL, BABA
Read
Saudis Admit Aramco Not Worth $2 Trillion: "It's A Much Tougher Sell Now"
Article By: Tyler Durden
Sunday, November 17, 2019 12:43 PM EDT
Saudi Aramco has finally set a price range for its IPO between $1.6 to $1.7 trillion, far below the $2 trillion levels the Saudi crown prince had imagined for the last several years, but priced higher than most institutional analysts.
Read
WeWork Lessons For Every Business
Article By: Bill Conerly
Sunday, November 17, 2019 11:54 AM EDT
WeWork’s disastrous attempt at a public offering provides lessons for everyday companies thinking about their business models. The core business issues were potential competition and the risk of long-term commitments to provide short-term rentals.
Read
Saudi Aramco: IPO Ahead
Article By: Lipper Alpha Insight
Thursday, November 14, 2019 10:23 AM EDT
Two trillion dollars is larger than the annual GDP of Canada – and the market valuation Saudi Aramco is hoping to achieve when it lists a portion of its state-owned company on the Saudi stock exchange (Tadawul).
In this article: BNO, XOM, OIL
Read
Week In Review: AstraZeneca Announces $1 Billion Fund For China Life Science Startups
Article By: ChinaBio® Today
Saturday, November 9, 2019 6:15 PM EDT
Deals, financings, trials and approvals in China biotech this past week.
In this article: AZN, SCR, CICC, BGNE
Read
Fastly Could Be Impacted By IPO Lockup Expiration
Article By: Don Dion
Friday, November 8, 2019 3:46 PM EDT
When the IPO lockup period ends for Fastly, Inc. on November 13th, the company's insiders and pre-IPO shareholders will have the opportunity to sell large blocks of currently-restricted shares, including 7.8 million Class B shares.
In this article: FSLY Also: ALK, NYT, GOOG, YELP, SHOP, GOOGL, PINS
Read
TELA Bio Announces Pricing Of Initial Public Offering Of Common Stock
Article By: NASDAQ GlobeNewswire
Thursday, November 7, 2019 9:12 PM EDT
TELA Bio, Inc. today announced the pricing of its initial public offering of 4,000,000 shares of common stock at a public offering price of $13.00 per share, before underwriting discounts and commissions, for gross proceeds of $52.0 million.
In this article: TELA
Read
Luckin Coffee Could Stumble When IPO Lockup Expires
Article By: Don Dion
Thursday, November 7, 2019 7:33 PM EDT
When the lockup period for Luckin Coffee ends on November 13th, its pre-IPO shareholders will have the opportunity to sell large blocks of currently-restricted shares.
In this article: LK
Read
IPO Mania: Don’t Get Sucked In
Article By: Bob Lang
Monday, November 4, 2019 12:24 PM EDT
The mania is a big smoke-and-mirror show. Valuation is often wildly out of step with the company’s actual worth, and profits are often years away.
In this article: TGLO, BYND, LYFT, UBER, PINS, ZM
Read
705 to 720 of 1834 Posts
<<< 1 ... 43 44 45 46 47 ... 115 >>>